
Dr. Erin DiMauro
- B.A. in Chemistry
Wesleyan University - Ph.D. in Organic Chemistry (2003)
University of Pennsylvania - Worked in the area of bifunctional catalysis
- Currently Principal Scientist at Amgen, Boston


links
https://www.linkedin.com/in/erin-dimauro-76b01915
https://www.facebook.com/erin.dimauro.5
Experience
Principal Scientist, Group Leader
Amgen
-
Medicinal Chemistry team lead and group leader on a variety of projects
spanning therapeutic areas (Neuroscience, Oncology, Inflammation) and
target classes (Ion channels, kinases, GPCRs, PARPs, proteases,
transporters).
- Extensive experience in lead generation and optimization: delivery of high quality tools for target validation and milestone leads for project advancement.
- Direct management of organizational units comprised of B.S., M.S., and Ph.D. Interns, Associates, Scientists, and Senior Scientists.
- Routine internal and external presentations. Consistent publication in leading journals.
- Extensive experience in lead generation and optimization: delivery of high quality tools for target validation and milestone leads for project advancement.
- Direct management of organizational units comprised of B.S., M.S., and Ph.D. Interns, Associates, Scientists, and Senior Scientists.
- Routine internal and external presentations. Consistent publication in leading journals.
Senior Scientist, Group Leader
Amgen
Education
Publications
The development of novel dual-binders as potent, selective, and orally bioavailable tankers inhibitors(Link)
J. Med. Chem. 2013, 56, 10003-10015
Structure-based design of 2-aminopyridine oxazolidinones as potent and selective tankyrase inhibitors(Link)
ACS Med. Chem. Lett. 2013, 4, 1218
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors(Link)
J. Med. Chem. 2013, 56, 4320-4342
Projects
GlyRa3 (Neuroscience)
Nav1.7 (Neuroscience)
Tankyrase (Oncology)
Ck1g (Oncology)
BACE (Neuroscience)
CB2 (Neuroscience)
Lck (Inflammation)



////////
No comments:
Post a Comment